©2023-2035 All Rights Reserved. Online
Journal of Veterinary Research . You may not store
these pages in any form except for your own personal use. All other usage or
distribution is illegal under international copyright treaties. Permission to
use any of these pages in any other way besides the
before mentioned
must be gained in writing from the publisher. This article is exclusively
copyrighted in its entirety to OJVR.This article may be copied once
but may not be, reproduced or re-transmitted without the express permission of
the editors. This journal satisfies the refereeing
requirements (DEST) for the Higher Education Research Data Collection
(Australia). Linking:To link to this
page or any pages linking to this page you must link directly to this page only
here rather than put up your own page.
OJVRTM
Online Journal of
Veterinary Research ©
(Including
Medical and Laboratory Research)
Established 1994
ISSN 1328-925X
Volume 28 (2): 77-89, 2024.
In Silico docking human glut5 protein
intestinal transport.
GV Padmavathi1, D Saralakumari1,
P Nataraj Sekhar2
1Department of Biochemistry, Sri Krishnadevaraya University, Anantapur,2Katholike University (Leuven),
Belgium.
Padmavathi GV, Saralakumari D, Nataraj
Sekhar P., In
Silico docking human glut5 protein intestinal transport, Onl
J Vet Res., 28 (2): 77-89,
2024. GLUT5 in enterocytes facilitates fructose transport from intestinal
lumen into blood. We constructed In silico 3D GLUT5
protein model interaction between sweeteners and inhibitors by crystal
structure of glutaminase glucosamine 6-phosphate synthase.
Model was designed by pico-second molecular dynamics simulation and minimization
assessed by ERRAT, WHATCHECK and PROCHECK. Docking studies between sweeteners
and inhibitors suggested fructose had most affinity but ingliforib
exhibited most interaction with GLUT5. Our findings suggested Asn 94, Lys156, Asn 157 and Gln 178 were required residues for hydrogen bond binding
with ligands.
Key words: GLUT5, homology modelling,
Molecular Dynamics, Docking.
FULL-TEXT (SUBSCRIBE OR PURCHASE TITLE)